Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes

Condition

  • Gastrointestinal symptoms

Study Name

Automated Evaluation of Gastrointestinal Symptoms (AEGIS): A Pragmatic Clinical Trial Evaluating the Impact of AEGIS on Clinical Outcomes (IRB no. 45243)

Summary

The purpose of this study is to evaluate the impact of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on clinical outcomes. AEGIS is a computer algorithm that is accessed through a secure website called My GI Health, which is an investigational software. Once on the website, AEGIS guides the participant through a series of questions to learn about their gastrointestinal symptoms. After completion, AEGIS creates a report about the symptoms, which the physician can review before seeing the patient in clinic.

My GI Health may uncover important information that might not otherwise be known and may allow physicians to provide care that is better suited to individual needs. My GI Health may also help the patient to communicate health issues to their physician.

Financial disclosure: Brennan Spiegel, MD, who is a co-investigator on the study, has a financial relationship with the sponsor. Please see additional information below.*

Eligibility

Key Inclusion Criteria

  • At least 18 years old
  • Gastrointestinal (GI) clinic patients
  • Individuals who do not have dementia or other cognitive disorders that would prevent ability to participate

Key Exclusion Criteria

  • Non-English speakers
  • Children

Please see detailed list of inclusion and exclusion criteria.

Principal Investigator

Christopher Almario, MD

Contact

Christopher V. Almario, MD, MSHPM
310-423-4462
christopher.almario@cshs.org


* This study is sponsored by the American College of Gastroenterology (ACG). Brennan Spiegel, MD, who is a co-investigator on the study, has a financial relationship with the sponsor as follows:

  • Serves on the ACG Board of Directors
  • Has ownership interest, stock options, or other financial interests related to the research whose value would be affected by the outcome of the research
  • Has equity interests (e.g., stock, stock options, or other ownership interests of any amount in a non-publicly-traded financially interested company); and
  • Receives royalty income or may receive future royalty income in the future based on a patent, or copyright, or other intellectual property directly related to this research